<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Lindesmith, Lisa C.</dc:creator>
  <dc:creator>Donaldson, Eric F.</dc:creator>
  <dc:creator>Beltramello, Martina</dc:creator>
  <dc:creator>Pintus, Stefania</dc:creator>
  <dc:creator>Corti, Davide</dc:creator>
  <dc:creator>Swanstrom, Jesica</dc:creator>
  <dc:creator>Debbink, Kari</dc:creator>
  <dc:creator>Jones, Taylor A.</dc:creator>
  <dc:creator>Lanzavecchia, Antonio</dc:creator>
  <dc:creator>Baric, Ralph S.</dc:creator>
  <dc:date>2014-07-22</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">GII.4 noroviruses (NoVs) are the primary cause of epidemic viral acute gastroenteritis. One primary obstacle to  successful NoV vaccination is the extensive degree of antigenic diversity among strains. The major capsid  protein of GII.4 strains is evolving rapidly, resulting in the emergence of new strains with altered blockade  epitopes. In addition to characterizing these evolving blockade epitopes, we have identified monoclonal  antibodies (MAbs) that recognize a blockade epitope conserved across time-ordered GII.4 strains. Uniquely, the  blockade potencies of MAbs that recognize the conserved GII.4 blockade epitope were temperature sensitive,  suggesting that particle conformation may regulate functional access to conserved blockade non-surface- exposed epitopes. To map conformation-regulating motifs, we used bioinformatics tools to predict conserved  motifs within the protruding domain of the capsid and designed mutant VLPs to test the impacts of substitutions  in these motifs on antibody cross-GII.4 blockade. Charge substitutions at residues 310, 316, 484, and 493  impacted the blockade potential of cross-GII.4 blockade MAbs with minimal impact on the blockade of MAbs  targeting other, separately evolving blockade epitopes. Specifically, residue 310 modulated antibody blockade  temperature sensitivity in the tested strains. These data suggest access to the conserved GII.4 blockade  antibody epitope is regulated by particle conformation, temperature, and amino acid residues positioned outside  the antibody binding site. The regulating motif is under limited selective pressure by the host immune response  and may provide a robust target for broadly reactive NoV therapeutics and protective vaccines.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://susi.usi.ch/global/documents/318986</dc:identifier>
  <dc:identifier>https://localhost:5000/ark:/12658/srd1318986</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/318986/files/Lindesmith_JV_2014.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1128/JVI.01192-14</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1318986</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Journal of virology. - 2014, vol. 88, no. 16, p. 8826-8842</dc:source>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
